300 related articles for article (PubMed ID: 25765106)
1. Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis.
Salamon H; Yamaguchi KD; Cirillo DM; Miotto P; Schito M; Posey J; Starks AM; Niemann S; Alland D; Hanna D; Aviles E; Perkins MD; Dolinger DL
J Infect Dis; 2015 Apr; 211 Suppl 2(Suppl 2):S50-7. PubMed ID: 25765106
[TBL] [Abstract][Full Text] [Related]
2. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM
J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
[TBL] [Abstract][Full Text] [Related]
3. Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review.
Papaventsis D; Casali N; Kontsevaya I; Drobniewski F; Cirillo DM; Nikolayevskyy V
Clin Microbiol Infect; 2017 Feb; 23(2):61-68. PubMed ID: 27665704
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis drug resistance mutation database.
Sandgren A; Strong M; Muthukrishnan P; Weiner BK; Church GM; Murray MB
PLoS Med; 2009 Feb; 6(2):e2. PubMed ID: 19209951
[TBL] [Abstract][Full Text] [Related]
5. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS
Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
[TBL] [Abstract][Full Text] [Related]
6. embB306 mutations as molecular indicators to predict ethambutol susceptibility in Mycobacterium tuberculosis.
Sirgel FA; Warren RM; Streicher EM; Victor TC; van Helden PD; Böttger EC
Chemotherapy; 2012; 58(5):358-63. PubMed ID: 23171739
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis drug resistance in an area of low endemicity in 2004 to 2006: semiquantitative drug susceptibility testing and genotyping.
Springer B; Calligaris-Maibach RC; Ritter C; Böttger EC
J Clin Microbiol; 2008 Dec; 46(12):4064-7. PubMed ID: 18923010
[TBL] [Abstract][Full Text] [Related]
8. Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing.
Pfyffer GE
Schweiz Med Wochenschr; 2000 Dec; 130(49):1909-13. PubMed ID: 11153397
[TBL] [Abstract][Full Text] [Related]
9. The ins and outs of Mycobacterium tuberculosis drug susceptibility testing.
Böttger EC
Clin Microbiol Infect; 2011 Aug; 17(8):1128-34. PubMed ID: 21631641
[TBL] [Abstract][Full Text] [Related]
10. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.
Kibiki GS; Mulder B; Dolmans WM; de Beer JL; Boeree M; Sam N; van Soolingen D; Sola C; van der Zanden AG
BMC Microbiol; 2007 May; 7():51. PubMed ID: 17540031
[TBL] [Abstract][Full Text] [Related]
11. Genotypic and phenotypic characteristics of aminoglycoside-resistant Mycobacterium tuberculosis isolates in Latvia.
Bauskenieks M; Pole I; Skenders G; Jansone I; Broka L; Nodieva A; Ozere I; Kalvisa A; Ranka R; Baumanis V
Diagn Microbiol Infect Dis; 2015 Mar; 81(3):177-82. PubMed ID: 25557624
[TBL] [Abstract][Full Text] [Related]
12. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology.
Tudó G; González J; Obama R; Rodríguez JM; Franco JR; Espasa M; Simarro PR; Escaramís G; Ascaso C; García A; Jiménez de Anta MT
Int J Tuberc Lung Dis; 2004 Jan; 8(1):15-22. PubMed ID: 14974741
[TBL] [Abstract][Full Text] [Related]
13. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis.
Palomino JC; Martin A; Von Groll A; Portaels F
J Microbiol Methods; 2008 Oct; 75(2):161-6. PubMed ID: 18627779
[TBL] [Abstract][Full Text] [Related]
14. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.
Shenai S; Rodrigues C; Sadani M; Sukhadia N; Mehta A
Indian J Tuberc; 2009 Apr; 56(2):82-90. PubMed ID: 19810590
[TBL] [Abstract][Full Text] [Related]
15. CASTB (the comprehensive analysis server for the Mycobacterium tuberculosis complex): A publicly accessible web server for epidemiological analyses, drug-resistance prediction and phylogenetic comparison of clinical isolates.
Iwai H; Kato-Miyazawa M; Kirikae T; Miyoshi-Akiyama T
Tuberculosis (Edinb); 2015 Dec; 95(6):843-844. PubMed ID: 26542225
[No Abstract] [Full Text] [Related]
16. Phenotypic and genotypic characteristics of drug resistance in Mycobacterium tuberculosis isolates from pediatric population of Chennai, India.
Therese KL; Gayathri R; Balasubramanian S; Natrajan S; Madhavan HN
Indian J Med Microbiol; 2012; 30(4):411-7. PubMed ID: 23183465
[TBL] [Abstract][Full Text] [Related]
17. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
Melzer M; Gupta N; Petersen I; Cook S; Hall B
Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
[TBL] [Abstract][Full Text] [Related]
18. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of clinical isolates of Mycobacterium tuberculosis collected from patients with persistent disease in the Khartoum region of Sudan.
Sharaf-Eldin GS; Saeed NS; Hamid ME; Jordaan AM; Van der Spuy GD; Warren RM; Van Helden PD; Victor TC
J Infect; 2002 May; 44(4):244-51. PubMed ID: 12099732
[TBL] [Abstract][Full Text] [Related]
20. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
Evans J; Stead MC; Nicol MP; Segal H
J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
